Table 4.
Cutoff values and median levels with positive rates of classical TMs and circulating ncRNAs under investigation in control (n = 25) and BC patients’ group (n = 70).
Groups | TMs | ncRNAs (Fold Change) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
CEA (ng/ml) | CA15-3 (U/ml) | LINC00511 | miR-185-3p | miR-301a-3p | ||||||
Cutoff | >1.66 | Median | >17.2 | Median | >0.97 | Median | ≤1.7 | Median | >0.59 | Median |
Control | 2 (8%) | 1.7 (1.6–1.8) | 0 (0%) | – | 0 (0%) | – | 4 (16%) | 0.67 (0.5–0.79) | 3 (12%) | 0.67 (0.591–1.6) |
BC | 53 (75.7%) | 2.9 (1.6–6.6) | 49 (70%) | 32.4 (20.3–90.6) | 64 (91.4%) | 2.02 (1.07–8.6) | 64 (91.4%) | 0.47 (0.01–1.6) | 60 (85.7%) | 3.9 (0.6–20.6) |
All data are presented as median (range) and the positivity rates are presented as (n, %).